2m 2m 2m 2m 2m 2m 2m
IOVANCE BTHRPTCS (IOVA)
NASDAQ
$4.53+$0.09 (+2.03%)
Price as of Jun 23, 2026 8:00 PM EDT- $1.8BMarket Cap
- 119.46%1-Year Change
- BiotechnologyIndustry
IOVANCE BTHRPTCS (IOVA)
$4.53+$0.09 (+2.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 263.5M +60.60% | 164.1M +13,698.99% | 1.2M +495.02% | -301,000 N/A | |
Cost of Revenue | 173.2M +39.67% | 124.0M +1,052.91% | 10.8M N/A | N/A N/A | |
Gross Profit | 90.3M +125.37% | 40.1M +518.93% | -9.6M +3,078.07% | -301,000 N/A | |
Sales and Marketing Expense | 51.5M +90.67% | 27.0M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -300.3M +6.35% | -282.3M -17.94% | -344.1M +16.72% | -294.8M +13.80% | |
Depreciation and Amortization Expense | 23.1M +8.84% | 21.2M +115.27% | 9.8M +5.79% | 9.3M +199.26% | |
Total Operating Expenses | 666.9M +19.22% | 559.3M +21.14% | 461.7M +15.76% | 398.9M +16.39% | |
Operating Profit | -403.4M +2.04% | -395.3M -14.17% | -460.6M +15.46% | -398.9M +16.39% | |
Interest Income | 10.3M -49.16% | 20.3M +55.43% | 13.0M +336.95% | 3.0M +561.86% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 10.3M -49.16% | 20.3M +55.43% | 13.0M +336.95% | 3.0M +561.86% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -393.0M +4.81% | -375.0M -16.20% | -447.5M +12.19% | -398.9M +16.39% | |
Income Taxes | -2.1M -26.77% | -2.8M -18.71% | -3.5M N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -391.0M +5.05% | -372.2M -16.18% | -444.0M +12.16% | -395.9M +15.67% | |
Net Income from Continuing Operations Applicable to Common | -393.0M +4.81% | -375.0M -16.20% | -447.5M +13.04% | -395.9M +15.67% | |
Basic EPS and Net Income | -1.09 -14.84% | -1.28 -32.28% | -1.89 -24.10% | -2.49 +11.66% | |
Diluted EPS and Net Income | -1.09 -14.84% | -1.28 -32.28% | -1.89 -24.10% | -2.49 +11.66% | |
Basic Weighted Average Shares | 357,345 +23.27% | 289,877 +23.28% | 235,131 +47.64% | 159,259 +3.82% | |
Diluted Weighted Average Shares | 357,345 +23.27% | 289,877 +23.28% | 235,131 +47.64% | 159,259 +3.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 163.1M +40.96% | 115.7M +0.70% | 114.9M -50.42% | 231.7M +196.22% | |
Short-Term Investments | 133.9M -35.65% | 208.1M +26.13% | 165.0M -31.29% | 240.1M -43.66% | |
Cash and Cash Equivalents and Short-Term Investments | 297.0M -8.28% | 323.8M +15.69% | 279.9M -40.69% | 471.8M -6.46% | |
Total Current Assets | 442.7M -3.14% | 457.0M +48.46% | 307.8M -35.75% | 479.1M -5.68% | |
Accumulated Depreciation | 48.8M +35.40% | 36.0M +29.04% | 27.9M +66.96% | 16.7M +92.40% | |
Property and Plant and Equipment and Net | 131.1M +20.20% | 109.1M -4.34% | 114.0M +8.36% | 105.2M +4.25% | |
Total Long-Term Assets | 8.2M +2,113.01% | 369,000 +36.67% | 270,000 +42.86% | 189,000 -89.41% | |
Total Assets | 913.2M +0.30% | 910.4M +16.67% | 780.4M +17.53% | 664.0M -14.58% | |
Income Taxes Payable | 31.8M -1.51% | 32.3M +86.29% | 17.3M N/A | N/A N/A | |
Total Short-Term Debt | 1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 138.4M +13.09% | 122.3M +10.91% | 110.3M +20.57% | 91.5M +2.56% | |
Total Long-Term Debt | 1.0M 0.00% | 1.0M 0.00% | 1.0M 0.00% | 1.0M 0.00% | |
Total Long-Term Liabilities | 76.2M -1.87% | 77.7M -9.07% | 85.4M +17.26% | 72.9M +9.61% | |
Total Liabilities | 214.6M +7.28% | 200.0M +2.19% | 195.7M +19.10% | 164.3M +5.57% | |
Retained Earnings | -2.8B +16.40% | -2.4B +18.49% | -2.0B +28.31% | -1.6B +33.77% | |
Total Stockholders Equity | 698.6M -1.66% | 710.4M +21.52% | 584.6M +17.01% | 499.6M -19.63% | |
Total Shares Outstanding | 411.9M +34.95% | 305.3M +19.18% | 256.1M +36.38% | 187.8M +19.62% | |
Cash Flow | |||||
Cash from Operating Activities | -302.4M -14.33% | -353.0M -2.44% | -361.8M +23.59% | -292.8M +28.44% | |
Capital Expenditures | 33.8M +205.68% | 11.1M -50.34% | 22.3M +9.13% | 20.4M -45.64% | |
Cash from Investing Activities | 47.5M +149.26% | -96.4M -37.90% | -155.2M -160.53% | 256.5M +194,184.09% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 300.8M -23.01% | 390.7M -15.62% | 463.0M +143.47% | 190.2M -20.53% | |
Financials Ratio | |||||
Gross Margin | 34.28% +40.33% | 24.43% +103.04% | -804.54% N/A | N/A N/A | |
Operating Margin | -153.08% -36.46% | -240.92% -99.38% | -38,734.99% -129.23% | 132,517.61% N/A | |
Return on Assets | -42.88% -2.60% | -44.02% -28.40% | -61.49% +11.93% | -54.93% +24.06% | |
Return on Equity | -55.50% -3.45% | -57.48% -29.82% | -81.91% +15.99% | -70.61% +31.85% | |
Revenue Growth | 60.60% -99.56% | 13,698.99% +2,667.38% | 495.02% N/A | N/A N/A | |
Current Ratio | 3.20 -14.35% | 3.74 +33.85% | 2.79 -46.71% | 5.24 -8.03% | |
Cash Ratio | 1.18 +24.64% | 0.95 -9.20% | 1.04 -58.88% | 2.53 +188.83% | |
Debt-to-Equity Ratio | 0.003 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.002 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow